Edge Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Edge Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,075	Closed	-$66K	–	126
2021 Q4	$66K	Sell	1,075 -400	-27%	-$27.7K	0.01%	158
2021 Q3	$110K	Hold	1,475	–	–	0.02%	123
2021 Q2	$137K	Hold	1,475	–	–	0.03%	111
2021 Q1	$131K	Buy	+1,475	New	+$146K	0.03%	111
2020 Q3	–	Sell	-1,750	Closed	-$91K	–	453
2020 Q2	$91K	Hold	1,750	–	–	0.02%	211
2020 Q1	$55K	Sell	1,750 -325	-16%	-$10.9K	0.01%	227
2019 Q4	$70K	Hold	2,075	–	–	0.01%	227
2019 Q3	$61K	Hold	2,075	–	–	0.01%	232
2019 Q2	$72K	Buy	2,075 +25	+1%	+$801	0.02%	221
2019 Q1	$67K	Hold	2,050	–	–	0.02%	215
2018 Q4	$49K	Buy	+2,050	New	+$57.8K	0.01%	248

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Edge Wealth Management's ARKG Position: Q1 2022 in Review

Edge Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 1,075 shares — an estimated $66K sold.

Edge Wealth Management first reported a position in ARKG in Q4 2018 and held it in 11 quarters. The position peaked at $137K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Edge Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 1,075 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $66K.
Edge Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 11 quarters.
Edge Wealth Management's ARK Genomic Revolution ETF position peaked at $137K in Q2 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.